How Wegovy and Mounjaro Starting Doses Actually Compare
Wegovy Starting Dose vs Mounjaro: The Key Differences
The Wegovy starting dose of 0.25mg weekly represents a significantly gentler introduction compared to Mounjaro's 2.5mg starting dose. Wegovy follows a five-step escalation over 16 weeks (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance), whilst Mounjaro uses six dose levels over a similar period. This difference reflects their distinct mechanisms—semaglutide in Wegovy targets GLP-1 receptors exclusively, whilst tirzepatide in Mounjaro activates both GIP and GLP-1 pathways. The lower Wegovy starting dose may reduce initial gastrointestinal side effects during the first month of treatment.
Both treatments require dose escalation every four weeks, and neither allows dose-skipping during the titration phase. Wegovy's maximum licensed dose is 2.4mg weekly (with 7.2mg approved by MHRA in January 2026 but not yet available), whilst Mounjaro reaches 15mg weekly at its highest level. The choice between these starting doses often depends on individual tolerance, medical history, and prescriber preference. At EverydayMeds, our clinical team can assess which Wegovy starting dose schedule or Mounjaro regimen aligns best with your weight management goals.
Pricing Comparison: Wegovy Starting Dose vs Mounjaro Costs
The Wegovy starting dose of 0.25mg costs £79.99 at EverydayMeds, making it the most affordable entry point for either treatment. Our Intro Duo bundle combines the 0.25mg and 0.5mg pens for £169.99, covering your first eight weeks of treatment. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive prices. Mounjaro's starting dose typically costs more due to its higher concentration and different manufacturing requirements.
For patients considering longer-term treatment planning, our Intro Trio bundle includes the first three Wegovy doses (0.25mg, 0.5mg, and 1mg) for £299.99, providing 12 weeks of stepped escalation. The Gentle Start Trio offers extended time at the Wegovy starting dose with two 0.25mg pens plus one 0.5mg pen for £269.99, ideal for those wanting a slower titration. All bundles include next-day delivery with temperature-controlled handling to maintain medication stability throughout transport.
Clinical Evidence for Wegovy Starting Dose Effectiveness
The STEP clinical trial programme demonstrated that Wegovy's starting dose escalation protocol contributed to sustained weight management outcomes. In STEP 1, participants following the full dose escalation from 0.25mg achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle modifications (Wilding et al., NEJM, 2021). The gradual Wegovy starting dose approach may help improve treatment adherence by minimising early discontinuation due to side effects.
STEP 5 trial data showed that patients maintaining the complete dose escalation protocol sustained approximately clinically studied weight loss at two years. The structured Wegovy starting dose regimen appears designed to optimise both tolerability and efficacy outcomes. However, individual results may vary significantly, and these figures represent average outcomes from controlled clinical trials rather than assured individual results.
How Wegovy Works: Understanding the Starting Dose Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone called glucagon-like peptide-1. The Wegovy starting dose of 0.25mg begins training your appetite regulation centres in the brain to recognise fullness signals more effectively. As the dose escalates weekly, this appetite suppression typically becomes more pronounced, helping you feel satisfied with smaller meal portions. The once-weekly injection schedule provides sustained hormone activity between doses. This mechanism works alongside a reduced-calorie diet and increased physical activity to support weight management goals.
Ordering Process: Getting Your Wegovy Starting Dose
Accessing your Wegovy starting dose through EverydayMeds begins with our 3-minute online clinical assessment covering your weight management history, current medications, and treatment goals. Our prescribers review applications within three working days (express 24-hour service available) to ensure Wegovy suits your individual circumstances. Once approved, your 0.25mg starter pen ships via next-day delivery in temperature-controlled packaging to maintain medication stability. The FlexTouch pen system requires no mixing or preparation—simply attach a new needle for each weekly injection. Our patient support team provides injection technique guidance and ongoing treatment monitoring throughout your dose escalation journey.
Storage Requirements: Wegovy Starting Dose Practical Considerations
Your Wegovy starting dose pen must be stored in the refrigerator between 2–8°C until first use to maintain medication potency. Once removed from refrigeration, Wegovy offers superior storage flexibility compared to Mounjaro—remaining stable for up to 6 weeks at room temperature below 30°C, whilst Mounjaro only maintains stability for 21 days. This makes Wegovy more convenient for travel or situations where refrigeration access is limited. The FlexTouch pen delivers precise 0.25mg doses through its built-in mechanism, and each pen contains four weekly doses before requiring replacement. Always store pens away from direct sunlight and never freeze the medication.
Wegovy Starting Dose vs Mounjaro: Side Effect Profiles
The lower Wegovy starting dose may result in fewer initial gastrointestinal effects compared to Mounjaro's higher starting concentration. Common early effects with both treatments include nausea, diarrhoea, and reduced appetite, though these typically diminish as your body adjusts to treatment. The gradual Wegovy starting dose escalation allows your digestive system to adapt progressively to the medication's effects. Clinical trials suggest that starting with 0.25mg and escalating slowly may improve long-term treatment adherence.
Both medications carry similar contraindications and require careful prescriber assessment before initiation. Neither should be used during pregnancy or breastfeeding, and both require monitoring in patients with gastrointestinal conditions. Your prescriber will evaluate which starting dose approach suits your medical history and tolerance profile. At EverydayMeds, our clinical team remains available for ongoing support throughout your treatment journey.
Making Your Choice: Next Steps for Wegovy Starting Dose
Both Wegovy and Mounjaro represent evidence-based weight management treatments available through EverydayMeds' GPhC-registered pharmacy service. The Wegovy starting dose offers a gentler introduction at £79.99, whilst Mounjaro provides dual-hormone targeting from the outset. Neither treatment is inherently superior—the choice depends on your individual medical profile, tolerance preferences, and prescriber recommendation. Our online clinical assessment evaluates your suitability for either medication, with prescribers selecting the most appropriate option based on your responses. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your assessment, and remember to apply discount code FIRST40 for new customers or DOSE25 for returning patients at checkout.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
